Pregnancy-Related and Perinatal Outcomes in Women With Multiple Sclerosis: A Nationwide Danish Cross-sectional Study
- PMID: 34484927
- PMCID: PMC8382416
- DOI: 10.1212/CPJ.0000000000001035
Pregnancy-Related and Perinatal Outcomes in Women With Multiple Sclerosis: A Nationwide Danish Cross-sectional Study
Abstract
Objective: To investigate differences in pregnancy-related and perinatal outcomes in women with multiple sclerosis (MS) compared with the general population.
Methods: We conducted a cross-sectional study including pregnancies from January 1, 1997, to December 31, 2016, to women registered in the Danish Multiple Sclerosis Registry (the study cohort). Pregnancy-related and perinatal outcomes were compared with a randomly selected subcohort of pregnancies from the general population (the comparison cohort) using logistic regression adjusted for possible confounders.
Results: In total, 2,930 pregnancies were included in the study cohort and 56,958 pregnancies in the comparison cohort. No differences were found in pregnancy-related complications (preeclampsia/gestational diabetes or placenta complications), emergency caesarean section (c-section), instrumental delivery, low Apgar score, stillbirth, preterm birth, or congenital malformations. Elective c-section (odds ratio [OR] 1.89 [95% confidence interval (CI) 1.65-2.16]), induced delivery (OR 1.15 [95% CI 1.01-1.31]), and being born small for gestational age (SGA) (OR 1.29 [95 %CI 1.04-1.60]) had a higher prevalence in the study cohort, whereas the prevalence of signs indicating asphyxia was lower in the study cohort (OR 0.87 [95% CI 0.78-0.97]) relative to the comparison cohort.
Conclusion: We found a higher prevalence of elective c-sections, induced delivery, and infants being SGA among newborns to women with MS, whereas the prevalence of asphyxia was lower in the study cohort. There were no significant differences in severe adverse perinatal outcomes when comparing women with MS and their newborns with those of the general population.
© 2021 American Academy of Neurology.
Figures
Similar articles
-
Pregnancy outcomes following maternal or paternal exposure to teriflunomide in the Danish MS population.Mult Scler Relat Disord. 2022 Mar;59:103529. doi: 10.1016/j.msard.2022.103529. Epub 2022 Jan 22. Mult Scler Relat Disord. 2022. PMID: 35091367
-
Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study.Am J Obstet Gynecol. 2021 Nov;225(5):522.e1-522.e11. doi: 10.1016/j.ajog.2021.05.016. Epub 2021 May 20. Am J Obstet Gynecol. 2021. PMID: 34023315 Free PMC article.
-
Outcomes of Pregnancies for Women Undergoing Endoscopy While They Were Pregnant: A Nationwide Cohort Study.Gastroenterology. 2017 Feb;152(3):554-563.e9. doi: 10.1053/j.gastro.2016.10.016. Epub 2016 Oct 20. Gastroenterology. 2017. PMID: 27773807
-
The impact of surgical therapies for inflammatory bowel disease on female fertility.Cochrane Database Syst Rev. 2019 Jul 23;7(7):CD012711. doi: 10.1002/14651858.CD012711.pub2. Cochrane Database Syst Rev. 2019. PMID: 31334846 Free PMC article.
-
Risk of stillbirth, preterm delivery, and fetal growth restriction following exposure in a previous birth: systematic review and meta-analysis.BJOG. 2018 Jan;125(2):183-192. doi: 10.1111/1471-0528.14906. Epub 2017 Oct 3. BJOG. 2018. PMID: 28856792
Cited by
-
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women's Health Registry (2020-2024).Mult Scler. 2025 Aug;31(9):1088-1101. doi: 10.1177/13524585251349125. Epub 2025 Jul 7. Mult Scler. 2025. PMID: 40621862 Free PMC article.
-
Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study.Mult Scler. 2023 May;29(6):731-740. doi: 10.1177/13524585231161492. Epub 2023 Apr 18. Mult Scler. 2023. PMID: 37073483 Free PMC article.
-
Maternal Multiple Sclerosis and Health Outcomes Among the Children: A Systematic Review.Clin Epidemiol. 2023 Mar 19;15:375-389. doi: 10.2147/CLEP.S392273. eCollection 2023. Clin Epidemiol. 2023. PMID: 36969978 Free PMC article. Review.
-
Pregnancy outcomes after early fetal exposure to injectable first-line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis.Eur J Neurol. 2023 Jan;30(1):162-171. doi: 10.1111/ene.15559. Epub 2022 Oct 1. Eur J Neurol. 2023. PMID: 36098960 Free PMC article.
-
Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy.J Neurol Neurosurg Psychiatry. 2024 May 14;95(6):561-570. doi: 10.1136/jnnp-2023-332804. J Neurol Neurosurg Psychiatry. 2024. PMID: 38124108 Free PMC article.
References
-
- Koch-Henriksen N, Sørensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010;9:520–532. - PubMed
-
- Koch-Henriksen N, Thygesen LC, Stenager E, Laursen B, Magyari M. Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women. Neurology 2018;90:1954–1963. - PubMed
-
- Fong A, Chau CT, Quant C, Duffy J, Pan D, Ogunyemi DA. Multiple sclerosis in pregnancy: prevalence, sociodemographic features, and obstetrical outcomes. J Matern Neonatal Med 2018;31:382–387. - PubMed
-
- Dahl J, Myhr KM, Daltveit AK, Hoff JM, Gilhus NE. Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology 2005;65:1961–1963. - PubMed
-
- Yalcin SE, Yalcin Y, Yavuz A, Akkurt MO, Sezik M. Maternal and perinatal outcomes in pregnancies with multiple sclerosis: a case-control study. J Perinat Med 2017;45:455–460. - PubMed
LinkOut - more resources
Full Text Sources